Telix Pharmaceuticals Limited (ASX: TLX)

Telix Pharmaceuticals Revenue

Telix Pharmaceuticals had revenue of 188.96M AUD in the quarter ending June 30, 2024, with 58.05% growth. This brings the company's revenue in the last twelve months to 645.68M, up 80.92% year-over-year. In the year 2023, Telix Pharmaceuticals had annual revenue of 502.55M with 213.90% growth.

• Revenue (ttm): 645.68M
• Revenue Growth: +80.92%
• P/S Ratio: 11.34
• Revenue / Employee: 1.53M
• Employees: 234
• Market Cap: 7.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	502.55M	342.45M	213.90%
Dec 31, 2022	160.10M	152.50M	2,007.64%
Dec 31, 2021	7.60M	2.38M	45.71%
Dec 31, 2020	5.21M	1.73M	49.58%
Dec 31, 2019	3.49M	3.29M	1,687.18%